Post-earnings recap
Reported
Wed, May 6, 2026
EPS actual
$0.29
EPS est.
$0.22
EPS surprise
+31.82%
1-day move
-1.77%
Guardian Pharmacy Services, Inc. reported better-than-expected earnings per share for Q1-2026, indicating stronger profitability than analysts anticipated. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. The stock reaction is not available, which may reflect investor caution or a lack of immediate market response to the earnings announcement.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.29 | $0.24 | +31.82% |
| Revenue | — | $330M | — |
No transcript is on record, and the analysis is based on numerical results only.
Guardian Pharmacy Services, Inc. operates in the health care sector, providing pharmacy services primarily to long-term care facilities. As the demand for specialized health care services continues to grow, Guardian plays a crucial role in ensuring that patients receive the medications they need in a timely and efficient manner.
Last quarter
In the last quarter, Guardian reported an EPS of $0.37, significantly beating estimates of $0.26. Despite the positive earnings surprise, the stock experienced a slight decline the following day.
EPS beat streak
5Q
EPS beat rate
100%
Avg EPS surprise
+27.69%
Avg 1-day reaction
-0.38%
Analysts expect Guardian to report solid earnings this quarter, with a consensus EPS of $0.24 and revenue of $330 million. The company has a strong track record of beating earnings expectations, which may lead to positive market sentiment.
Bull case
If Guardian continues its trend of exceeding earnings expectations, it could see a significant boost in stock price, especially given the current market's focus on health care services.
Bear case
On the other hand, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price, especially given the high implied volatility in the options market.
Key metrics to watch
EPS
0.24Earnings per share is a key indicator of a company's profitability and financial health.
Revenue
330MRevenue figures provide insight into the company's sales performance and market demand.
The print will turn on these.
Q1
Will Guardian's EPS exceed the consensus estimate of $0.24?
Given the company's history of beating earnings estimates, this will be a key indicator of its ongoing financial health.
Q2
What guidance will management provide regarding future revenue growth?
Future revenue guidance will be crucial for investor sentiment and could significantly impact the stock price.
—
Est. EPS
$0.01
Est. Rev
$918M
Impl. Move
±9.1%
Why consensus could be wrong
The Street may be underestimating Guardian's ability to leverage its recent successes into continued growth, especially given the strong demand for health care services.
Supporting evidence
Guardian has consistently beaten EPS estimates, suggesting a trend that may continue this quarter.
The high implied volatility in options indicates that traders are expecting significant movement, which may not align with consensus expectations.
Key risk
If Guardian's revenue growth significantly outpaces expectations, it could challenge the current consensus outlook.
Pre-commit to what would confirm each case.
The market is closely watching Guardian's ability to maintain its growth trajectory amidst increasing competition in the health care services sector.
Bull confirmed if
An EPS of $0.25 or higher, along with strong revenue growth, would confirm the bull case.
Bear confirmed if
An EPS below $0.23 or revenue significantly below $324 million would confirm the bear case.
What the market is pricing for the move.
Implied Move
±9.75%
Historical Avg
±1.7%
The options market is pricing in a significant move following the earnings report, indicating that traders expect volatility.
Options are pricing ±9.8% while GRDN has averaged ±1.7% over the last 5 prints — setup is pricing rich.
ATM IV
0.8%
30d HV
40.7%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: X of Y (Z%)
This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 3.3%, with a raw directional average of +2.1% (modestly positive historical bias).
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Guardian beats expectations, history suggests a potential stock increase of around +0.81%, confirming the company's strong performance.
In line / cautious
If results are in line with expectations, the stock may see a muted reaction as investors await further commentary from management.
Miss
If Guardian misses expectations, the stock could decline, with historical patterns suggesting a potential drop of around -0.45%.
The lines on the call that would change the story.